HOPE Valley AI develops a smartphone-based e-Clinic that utilizes Trustworthy Risk-Informed Artificial Intelligence to predict breast cancer risk and detect early signs of abnormalities. This technology addresses the challenge of late-stage breast cancer diagnoses by empowering patients to monitor their breast health and enabling healthcare providers to identify potential issues before they escalate.
Funding
Funding not disclosed
Founders
Product
Problem
Late-stage diagnosis of breast cancer remains a significant challenge, leading to decreased survival rates. Current methods often rely on infrequent mammograms, potentially missing interval cancers that develop between screenings. Many women are unaware of their individual risk factors and lack tools for proactive breast health monitoring.
Solution
HOPE Valley AI offers a smartphone-based digital clinic that uses AI to predict breast cancer risk and facilitate early detection. The platform empowers patients to conduct regular breast health self-checks under the supervision of their healthcare provider. By integrating risk-informed AI, the application aims to identify subtle indicators of potential abnormalities, enabling timely intervention and improved outcomes. The technology assists in "knowing my normal" by tracking changes and reporting any unusual symptoms or weak signals to the user and their physician.
Target Audience
The primary target audience includes women seeking proactive breast health management and healthcare providers looking for tools to improve early detection and risk assessment.
Features
- AI-powered risk prediction based on individual health data and risk factors
- Guided breast self-examination with abnormality detection and reporting
- Monitoring of breast skin changes, lumps, nipple discharge, and other symptoms
- Secure data storage and transmission to healthcare providers
- Personalized breast health education and awareness resources